The effect of ursodeoxycholic acid in children with prolonged hepatitis A virus infection that may be a trigger factor for autoimmune hepatitis [11]

American Journal of Gastroenterology

Volumn 96, Issue 2, 2001, Pages 610-611

  Koçak, Nurten ^a   Saltik, Inci Nur ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

COLESTYRAMINE; LIVER ENZYME; SMOOTH MUSCLE ANTIBODY; URSODEOXYCHOLIC ACID;

ABDOMINAL PAIN; ADOLESCENT; ANOREXIA; AUTOIMMUNE HEPATITIS; CASE REPORT; CHOLESTASIS; CLINICAL FEATURE; DIAGNOSTIC IMAGING; FATIGUE; HEPATITIS A; HEPATOSPLENOMEGALY; HUMAN; LETTER; MALAISE; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SYMPTOM; TREATMENT OUTCOME;

EID: 0035123380     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02370-4     Document Type: Letter

References (7)

1. Ursodeoxycholic acid therapy in children with cholestatic liver disease
2. Mechanism of hepatoprotective action of bile salts in liver disease
3. Effect of ursodeoxycholic acid administration in patients with acute viral hepatitis: A pilot study
4. Effect of ursodeoxycholic acid in acute viral hepatitis
5. Clinical manifestations of hepatitis A: Recent experience in a community teaching hospital
6. Autoimmune hepatitis in a genetically susceptible patients. Is it triggered by acute viral hepatitis A?
7. Acute hepatitis A virus (HAV). Association with fulminant hepatic failure (FHF) and autoimmune hepatitis (AIH) in pediatric population